3.67 USD
+0.16 (+4.56%)
Related screens
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-30 | Maxim Group | Maintains | Buy -> Buy |
| 2024-12-12 | Maxim Group | Initiate | Buy |
| 2024-03-07 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-06-05 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2022-08-03 | Ladenburg Thalmann | Initiate | Buy |
| 2022-06-23 | Goldman Sachs | Maintains | Neutral |
| 2021-08-20 | Benchmark | Initiate | Speculative Buy |
ALTERITY THERAPEUTICS-ADR / ATHE FAQ
What is the consensus rating for ATHE stock?
The consensus rating for ALTERITY THERAPEUTICS-ADR (ATHE) is 100 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ATHE stock?
The number of analysts covering ALTERITY THERAPEUTICS-ADR (ATHE) is 1.